The Register · A provider

National Institute of Psychiatry

Mexico City · Mexico

Specialties

psychiatric research rTMS clinical trials Psychiatric research Psychedelic medicine research psychedelic medicine research depression treatment research

Reports that name this provider

ECT/TMS Availability in Mexico: Clinical Research Division; approved by its Ethics Committee
Psilocybin Treatment Legality in Mexico: Designed and published the first psychedelic medicine protocol in Mexico in August 2023 to test Psilocybe cubensis for treating major depressive disorder
Psychedelic Treatment Quality in Mexico: Developed the first psychedelic medicine protocol published in Mexico in August 2023. Designed research protocol to test Psilocybe cubensis as an alternative to treat major depressive disorder.

← Back to all clinics